Beta Bionics, Inc. (BBNX) Other Non-Current Liabilities (2023 - 2026)
Beta Bionics (BBNX) posted Other Non-Current Liabilities of $1.6 million for Q1 2026, up 0.71% sequentially from $1.5 million in Q4 2025, and up 289.5% YoY from $400000.0 in Q1 2025.
Beta Bionics, Inc. (BBNX) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
Beta Bionics (BBNX) has 4 years of Other Non-Current Liabilities data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 289.5% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 289.5% YoY) and the FY2025 annual result came in at $1.5 million, down 96.55% from the prior year.
- Other Non-Current Liabilities improved to $1.6 million in Q1 2026 per BBNX's latest filing, from $1.5 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $44.9 million in Q4 2024, with the low at $400000.0 in Q1 2025.
- Average Other Non-Current Liabilities over 4 years is $10.4 million, with a median of $1.5 million recorded in 2025.
- Year-over-year, Other Non-Current Liabilities tumbled 96.55% in 2025 and jumped 289.5% in 2026.
- Beta Bionics' Other Non-Current Liabilities stood at $22.3 million in 2023, then surged by 101.15% to $44.9 million in 2024, then slumped by 96.55% to $1.5 million in 2025, then increased by 0.71% to $1.6 million in 2026.
- Business Quant data shows BBNX's Other Non-Current Liabilities at $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 44.90 Mn |
| Dec 31, 2023 | 22.32 Mn |